Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-12-01
|
Series: | Cancer Immunology, Immunotherapy |
Online Access: | https://doi.org/10.1007/s00262-024-03873-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|